Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.35 by 45.4 percent. This is a 52.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $654.800 million which beat the analyst consensus estimate of $637.774 million by 2.67 percent. This is a 34.66 percent increase over sales of $486.265 million the same period last year.